ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print February 2, 2006, 10.1183/09031936.06.00062805
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, G. V.
Right arrow Articles by Stradling, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, G. V.
Right arrow Articles by Stradling, J. R.
Eur Respir J 2006; 27:1229-1235
Copyright ©ERS Journals Ltd 2006

Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients

G. V. Robinson, D. M. Smith, B. A. Langford, R. J. O. Davies and J. R. Stradling

Oxford Centre for Respiratory Medicine, Oxford Radcliffe Hospitals NHS Trust, Churchill Hospital Site, Oxford, UK.

CORRESPONDENCE: G. V. Robinson, Oxford Centre for Respiratory Medicine, Oxford Radcliffe Hospitals NHS Trust, Churchill Hospital Site, Oxford, OX3 7LJ, UK, Fax: 44 1865225221. E-mail: gracevrobinson{at}yahoo.co.uk

Keywords: Cardiovascular risk, continuous positive airway pressure, hypertension, obstructive sleep apnoea

Received: May 30, 2005
Accepted January 20, 2006

Obstructive sleep apnoea (OSA) is associated with high cardiovascular morbidity and mortality. Several randomised controlled trials have shown that continuous positive airway pressure (CPAP) treatment of OSA reduces blood pressure (BP). This randomised, sham-placebo controlled crossover trial assesses whether CPAP produces a similar clinically significant fall in BP in hypertensive OSA patients, but without hypersomnolence.

Thirty-five, nonsleepy, hypertensive patients with OSA were treated with CPAP for 1 month, randomised first to either therapeutic or sham-placebo (subtherapeutic CPAP, about 1 cmH2O pressure). The second months' alternative treatment followed a 2-week washout period. BP was measured over 24 h, before and at the end of the two treatment periods: mean 24-h BP was the primary outcome variable.

There was no overall significant difference in mean 24-h BP: the change in mean 24-h BP on therapeutic CPAP was -2.1 mmHg (SD 8.1), and -1.1 mmHg (SD 8.1) on subtherapeutic CPAP, with a difference of 0.7 mmHg (95% confidence interval (CI) +2.9– -4.4). There was a small significant fall in Epworth Sleepiness Score, therapeutic (-1.4) versus sham (-0.3), and difference -1.2 (95% CI -2.0– -0.4), but no change in objective sleepiness.

In nonhypersomnolent hypertensive patients with obstructive sleep apnoea, there is no significant fall in mean 24-h blood pressure with continuous positive airway pressure, in contrast to the fall seen in hypersomnolent patients with obstructive sleep apnoea.




This article has been cited by other articles:


Home page
ChestHome page
C. L. Phillips, B. Yee, Q. Yang, A. T. Villaneuva, J. Hedner, N. Berend, and R. Grunstein
Effects of Continuous Positive Airway Pressure Treatment and Withdrawal in Patients With Obstructive Sleep Apnea on Arterial Stiffness and Central BP
Chest, July 1, 2008; 134(1): 94 - 100.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. H. Sanders, J. M. Montserrat, R. Farre, and R. J. Givelber
Positive Pressure Therapy: A Perspective on Evidence-based Outcomes and Methods of Application
Proceedings of the ATS, February 15, 2008; 5(2): 161 - 172.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
B. Buyse, J. Hedner, and the participants of working group 2
Sleep apnoea, hypertension and vascular disease: where are we now?
Eur. Respir. Rev., December 1, 2007; 16(106): 169 - 182.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. Campos-Rodriguez, J. Perez-Ronchel, A. Grilo-Reina, J. Lima-Alvarez, M. A. Benitez, and C. Almeida-Gonzalez
Long-term Effect of Continuous Positive Airway Pressure on BP in Patients With Hypertension and Sleep Apnea
Chest, December 1, 2007; 132(6): 1847 - 1852.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. T. McNicholas
Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1666 - R1670.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. A. Bazzano, Z. Khan, K. Reynolds, and J. He
Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea
Hypertension, August 1, 2007; 50(2): 417 - 423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. M. Montserrat, F. Garcia-Rio, and F. Barbe
Diagnostic and Therapeutic Approach to Nonsleepy Apnea
Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 6 - 9.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. Patruno, S. Aiolfi, G. Costantino, R. Murgia, C. Selmi, A. Malliani, and N. Montano
Fixed and Autoadjusting Continuous Positive Airway Pressure Treatments Are Not Similar in Reducing Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea
Chest, May 1, 2007; 131(5): 1393 - 1399.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. Haentjens, A. Van Meerhaeghe, A. Moscariello, S. De Weerdt, K. Poppe, A. Dupont, and B. Velkeniers
The Impact of Continuous Positive Airway Pressure on Blood Pressure in Patients With Obstructive Sleep Apnea Syndrome: Evidence From a Meta-analysis of Placebo-Controlled Randomized Trials
Arch Intern Med, April 23, 2007; 167(8): 757 - 764.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. R. Coughlin, L. Mawdsley, J. A. Mugarza, J. P. H. Wilding, and P. M. A. Calverley
Cardiovascular and metabolic effects of CPAP in obese males with OSA
Eur. Respir. J., April 1, 2007; 29(4): 720 - 727.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D S Hui, K W To, F W Ko, J P Fok, M C Chan, J C Ngai, A H Tung, C W Ho, M W Tong, C-C Szeto, et al.
Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness
Thorax, December 1, 2006; 61(12): 1083 - 1090.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.